William Benton Jones insider trades: Corvus Pharmaceuticals (CRVS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 6, 2024 | CRVS | ↑ Buy | 20,000 | $1.73 | $35K | Direct | May 7, 2024 (1d) |
| Dec 20, 2022 | CRVS | ↑ Buy | 20,000 | $0.79 | $16K | Direct | Dec 20, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRVS insiders
Open-market trades in the last 12 months
About William Benton Jones's insider trades
William Benton Jones is See Remarks at Corvus Pharmaceuticals (CRVS). Since Dec 20, 2022, William has reported 2 open-market purchases worth $50K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), option exercises (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.